And it may well be that Benitec have already considered the option of a second chance offering of TT-034 delivered with a different vector to those gutsy volunteers prepared to go with the early and purportedly sub-theraputic test doses of TT-034. If Benitec haven't made this offer already then I respectfully suggest that they consider doing so. It would be the decent thing to do and might also aid in recruiting suitable participants to the early low dose cohorts.
- Forums
- ASX - By Stock
- BLT
- run away train
run away train, page-40
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online